EMERGENT BIOSOLUTIONS INC (EBS)
US29089Q1058 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 111.70M | 642.60M | 576.10M | 621.30M | 167.80M | |||
| Receivables | 191.00M | 159.20M | 274.70M | 272.00M | 275.30M | |||
| Inventories | 328.90M | 350.70M | 350.80M | 307.00M | 222.50M | |||
| Other Current Assets | 47.90M | 57.90M | 70.50M | -4.40M | 20.60M | |||
| Total Current Assets | 679.50M | 1.21B | 1.27B | 1.20B | 686.20M | |||
| Non-Current Assets | ||||||||
| PPE Net | 399.00M | 837.00M | 828.40M | 675.10M | 567.00M | |||
| Goodwill | 0.00 | 218.20M | 224.90M | 266.70M | 266.60M | |||
| Intangibles | 566.60M | 728.80M | 604.60M | 663.10M | 741.90M | |||
| Other Non-Current Assets | 178.10M | 171.90M | 29.00M | 82.40M | 65.60M | |||
| Total Non-Current Assets | 1.14B | 1.96B | 1.69B | 1.69B | 1.64B | |||
| TOTAL ASSETS | 1.82B | 3.17B | 2.96B | 2.88B | 2.33B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 413.70M | 957.30M | 31.60M | 33.80M | 12.90M | |||
| Accrued Expenses | 96.20M | 128.00M | 146.20M | 136.90M | 105.50M | |||
| Accounts Payable | 112.20M | 103.50M | 128.90M | 136.10M | 94.80M | |||
| Other Current Liabilities | 29.20M | 40.10M | 67.10M | 77.70M | 3.10M | |||
| Total Current Liabilities | 651.30M | 1.23B | 373.80M | 384.50M | 216.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 446.50M | 448.50M | 809.40M | 841.00M | 798.40M | |||
| Deferred Taxes/Income | 47.20M | 59.70M | 94.90M | 53.20M | 63.90M | |||
| Other Non-Current Liabilities | 28.90M | 41.50M | 61.90M | 157.50M | 160.20M | |||
| Total Non-Current Liabilities | 522.60M | 549.70M | 966.20M | 1.05B | 1.02B | |||
| TOTAL LIABILITIES | 1.17B | 1.78B | 1.34B | 1.44B | 1.24B | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -21.80M | 738.70M | 957.80M | 726.90M | 421.80M | |||
| Additional Paid In Capital | 904.40M | 873.50M | 829.40M | 784.90M | 716.10M | |||
| Common Shares | 100.00K | 100.00K | 100.00K | 100.00K | 100.00K | |||
| Treasury Stock | -227.70M | -227.70M | -152.20M | -39.60M | -39.60M | |||
| Other Shareholders' Equity | -5.70M | 3.10M | -16.10M | -25.30M | -9.90M | |||
| Shares Outstanding | 52.20M | 50.10M | 51.30M | 53.10M | 51.70M | |||
| Tangible Book Value per Share | 1.58 | 8.80 | 15.39 | 9.74 | 1.55 | |||
| Total Shareholders' Equity | 649.30M | 1.39B | 1.62B | 1.45B | 1.09B | |||
| TOTAL LIABILITIES AND EQUITY | 1.82B | 3.17B | 2.96B | 2.88B | 2.33B | |||
| Statistics | ||||||||
| Debt/Equity | 0.69 | 0.32 | 0.50 | 0.58 | 0.73 | |||
| Current Ratio | 1.04 | 0.98 | 3.40 | 3.11 | 3.17 | |||
| Return On Assets (ROA) | -41.71% | -6.68% | 7.42% | 10.58% | 2.34% | |||
| Return On Equity (ROE) | -117.13% | -15.25% | 13.56% | 21.09% | 5.01% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | 11.71% | 15.18% | 4.27% | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | 15.06% | 20.20% | 4.64% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | N/A | 25.66% | 40.03% | 9.64% | |||
All data in USD